IMRIS Announces Growth Financing from Trinity Capital, Inc.

Minneapolis, MN (April 28, 2022) – IMRIS, Deerfield Imaging, the global leader in intraoperative imaging suites for neurosurgery and related surgical indications, announced today a new partnership with Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity”) for its latest capital raise. Trinity is a leading provider of debt and equipment financing to growth stage companies and has funded over $1.6 Billion across 186 companies.

“We are excited to partner with Trinity Capital in financing the next stage of our growth in intraoperative MRI surgical suites and related clinical products,” said Marc Buntaine, IMRIS’ Chief Executive Officer. “This partnership with Trinity is integral to unlocking our growth strategies in this dynamic market. We remain committed to delivering the world’s foremost neurosurgery intraoperative imaging suites, and now IMRIS is entering a new phase of growth, bringing new clinical value to our current and future customers and improving patient outcomes.”

Added Bob D’Acquisto, Managing Director of Trinity Capital, “We are excited about working with the team at IMRIS as they grow their core business to new levels of excellence. Along with being a leader in designing and installing intraoperative surgical suites, their team is also branching into new areas, bringing clinical value to their customers. We look forward to supporting them in this endeavor and being a part of their growth story.”

About IMRIS, Deerfield Imaging

IMRIS, Deerfield Imaging is the world leader in designing, installing, and supporting the most technically advanced neurosurgery intraoperative imaging suites. Complete with diagnostic and surgical dual application of MRI and other imaging modalities, IMRIS, with its “Moving Magnet” technology, provides the gold standard of hybrid imaging surgical suites installed in the world’s leading hospitals across the globe.

About Trinity Capital

Trinity Capital (Nasdaq: TRIN), an internally managed specialty lending company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, is a leading provider of debt, including loans and equipment financing, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital’s investment objective is to generate current income and, to a lesser extent, capital appreciation through investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies.